Pages that link to "Q34415738"
Jump to navigation
Jump to search
The following pages link to Adoptive T cell therapy using antigen-specific CD8 T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells (Q34415738):
Displaying 50 items.
- TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu (Q21131200) (← links)
- Focus on Adoptive T Cell Transfer Trials in Melanoma (Q21328679) (← links)
- Strategies of tumor immune evasion (Q22305820) (← links)
- Central memory self/tumor-reactive CD8 T cells confer superior antitumor immunity compared with effector memory T cells (Q24530100) (← links)
- Adoptive immunotherapy for cancer: building on success (Q24546258) (← links)
- Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma (Q24548019) (← links)
- Treatment of metastatic melanoma with autologous CD4 T cells against NY-ESO-1 (Q24633445) (← links)
- T cell receptor gene therapy for cancer (Q24634774) (← links)
- Adoptive cell transfer: a clinical path to effective cancer immunotherapy (Q24644774) (← links)
- Fever therapy revisited (Q24650460) (← links)
- Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10 (Q24672380) (← links)
- Adoptive T cell therapy for cancer in the clinic (Q24680405) (← links)
- Diversity and recognition efficiency of T cell responses to cancer (Q24796652) (← links)
- Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4 and CD8 T cells (Q24802970) (← links)
- Adoptive T cell therapy: Addressing challenges in cancer immunotherapy (Q24805804) (← links)
- Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model (Q24805875) (← links)
- Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes (Q24806024) (← links)
- Progress and controversies in developing cancer vaccines (Q24810256) (← links)
- Effector, Memory, and Dysfunctional CD8( ) T Cell Fates in the Antitumor Immune Response (Q26744527) (← links)
- Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects (Q26753082) (← links)
- T Cells and Cancer: How Metabolism Shapes Immunity (Q26766427) (← links)
- CAR T cells for solid tumors: armed and ready to go? (Q26825489) (← links)
- Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers (Q26830028) (← links)
- T lymphocytes targeting native receptors (Q26853345) (← links)
- Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation (Q26863724) (← links)
- HIV-1 functional cure: will the dream come true? (Q26865803) (← links)
- Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy? (Q27002575) (← links)
- Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook (Q27004178) (← links)
- Novel immunotherapeutic strategies of gastric cancer treatment (Q27011232) (← links)
- Chimeric antigen receptor therapy for cancer (Q27013599) (← links)
- Cancer immunotherapy (Q27026870) (← links)
- Advances in the treatment of metastatic melanoma: adoptive T-cell therapy (Q27027803) (← links)
- Proliferation-linked apoptosis of adoptively transferred T cells after IL-15 administration in macaques (Q27314843) (← links)
- T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it? (Q27335110) (← links)
- Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labeling (Q27340657) (← links)
- Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination (Q28068378) (← links)
- Technical Considerations for the Generation of Adoptively Transferred T Cells in Cancer Immunotherapy (Q28073563) (← links)
- Synthetic Nanoparticles for Vaccines and Immunotherapy (Q28085375) (← links)
- Adoptive transfer of Mammaglobin-A epitope specific CD8 T cells combined with a single low dose of total body irradiation eradicates breast tumors (Q28386603) (← links)
- Cancer immunotherapy via dendritic cells (Q29615444) (← links)
- Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics. (Q30382749) (← links)
- The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination? (Q30425111) (← links)
- In vivo imaging of T cell delivery to tumors after adoptive transfer therapy. (Q30479855) (← links)
- IL-21 mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8 cytotoxic T lymphocytes (Q30481064) (← links)
- Two-photon imaging of intratumoral CD8 T cell cytotoxic activity during adoptive T cell therapy in mice (Q30481516) (← links)
- Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses (Q30496118) (← links)
- Longitudinal confocal microscopy imaging of solid tumor destruction following adoptive T cell transfer. (Q30565493) (← links)
- Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8( ) T cells (Q30591778) (← links)
- Redirecting human CD4 T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha (Q33208099) (← links)
- Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy (Q33210267) (← links)